← Open Payments lookup

ALINA KIEVSKY: Open Payments

NPI 1295009306 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$952 in 46 payments from 14 companies in 2025. Trend: 2023 $844 · 2024 $864 · 2025 $952

Food & beverage: $952
CompanyPaymentsAmount
Amgen Inc.15$235
Lilly USA, LLC7$188
Novo Nordisk Inc5$113
Novartis Pharmaceuticals Corporation5$95
Salix Pharmaceuticals, a division of Bausch Health US, LLC4$82
Boehringer Ingelheim Pharmaceuticals, Inc.2$59
Dexcom, Inc.1$31
ABBVIE INC.1$31
AstraZeneca Pharmaceuticals LP1$26
Astellas Pharma US Inc1$20

Products named: MOUNJARO, OTEZLA, LEQVIO, XIFAXAN, Wegovy, EVENITY, Repatha, Dexcom G6 Transmitter.

Industry payments across CA — which companies pay providers there.